|
|||||
|
|
Pathological factors associated with survival benefit from adjuvant chemotherapy (ACT): a population‐based study of bladder cancer |
|
| Authors: | Alejo Rodriguez‐Vida Diletta Bianchini Mieke Van Hemelrijck Simon Hughes Zafar Malik Thomas Powles Amit Bahl Sarah Rudman Heather Payne Johann de Bono Simon Chowdhury |
| Affiliation: | 1. Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, UK;2. Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK;3. King's College London, Division of Cancer Studies, Cancer Epidemiology Group, London, UK;4. Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, UK;5. St. Bartholomew's Hospital NHS Foundation Trust, London, UK;6. University Hospitals Bristol NHS Foundation Trust, Bristol, UK;7. University College Hospital, London, UK |
| Abstract: | |
| Keywords: | castration‐resistant prostate cancer enzalutamide antiandrogen withdrawal syndrome hormone therapy androgen receptor targeting androgen receptor gene F876L mutation |